Hair transplantation is a well-established treatment for androgenetic alopecia (AGA), yet the long-term success of grafts can vary due to multiple influencing factors. Platelet-rich plasma (PRP) has gained attention as a potential adjunctive therapy aimed at enhancing graft survival and promoting hair regrowth. This systematic review evaluated the clinical efficacy of PRP when used alongside hair transplantation. A comprehensive search of Scopus, MEDLINE (via PubMed), and DOAJ was conducted from…

Hair transplantation is a well-established treatment for androgenetic alopecia (AGA), yet the long-term success of grafts can vary due to multiple influencing factors. Platelet-rich plasma (PRP) has gained attention as a potential adjunctive therapy aimed at enhancing graft survival and promoting hair regrowth. This systematic review evaluated the clinical efficacy of PRP when used alongside hair transplantation. A comprehensive search of Scopus, MEDLINE (via PubMed), and DOAJ was conducted from…

Hair transplantation is a well-established treatment for androgenetic alopecia (AGA), yet the long-term success of grafts can vary due to multiple influencing factors. Platelet-rich plasma (PRP) has gained attention as a potential adjunctive therapy aimed at enhancing graft survival and promoting hair regrowth. This systematic review evaluated the clinical efficacy of PRP when used alongside hair transplantation. A comprehensive search of Scopus, MEDLINE (via PubMed), and DOAJ was conducted from…

Hair transplantation is a well-established treatment for androgenetic alopecia (AGA), yet the long-term success of grafts can vary due to multiple influencing factors. Platelet-rich plasma (PRP) has gained attention as a potential adjunctive therapy aimed at enhancing graft survival and promoting hair regrowth. This systematic review evaluated the clinical efficacy of PRP when used alongside hair transplantation. A comprehensive search of Scopus, MEDLINE (via PubMed), and DOAJ was conducted from…

Hair transplantation is a well-established treatment for androgenetic alopecia (AGA), yet the long-term success of grafts can vary due to multiple influencing factors. Platelet-rich plasma (PRP) has gained attention as a potential adjunctive therapy aimed at enhancing graft survival and promoting hair regrowth. This systematic review evaluated the clinical efficacy of PRP when used alongside hair transplantation. A comprehensive search of Scopus, MEDLINE (via PubMed), and DOAJ was conducted from…

CONCLUSION: Main pathology is considered the hair miniaturization rather than inflammation-mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.

CONCLUSION: Main pathology is considered the hair miniaturization rather than inflammation-mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.

CONCLUSION: Main pathology is considered the hair miniaturization rather than inflammation-mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.

CONCLUSION: Main pathology is considered the hair miniaturization rather than inflammation-mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.

CONCLUSION: Main pathology is considered the hair miniaturization rather than inflammation-mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.

CONCLUSION: Main pathology is considered the hair miniaturization rather than inflammation-mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.

CONCLUSION: Main pathology is considered the hair miniaturization rather than inflammation-mediated change in the chronic phase of hair loss. Therapies targeting follicular miniaturization, exemplified by topical minoxidil, have the potential to induce hair regrowth.